Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Tegafur

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 221Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    European Commission approves Teysuno in metastatic colorectal cancer
    European Commission approves Teysuno in metastatic colorectal cancer

    31 Jan 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/european-commission-approves-teysuno-in-metastatic-colorectal-cancer-301470829.html

    PRNEWSWIRE
    31 Jan 2022
    Share Share
    Positive EMA opinion for the use of Teysuno in metastatic colorectal cancer
    Positive EMA opinion for the use of Teysuno in metastatic colorectal cancer

    04 Jan 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/positive-ema-opinion-for-the-use-of-teysuno-in-metastatic-colorectal-cancer-301453395.html

    PRNEWSWIRE
    04 Jan 2022
    Share Share
    EMA recommendations on DPD testing prior to treatment with fluorouracil
    EMA recommendations on DPD testing prior to treatment with fluorouracil

    01 May 2020

    // EMA

    https://www.ema.europa.eu/en/news/ema-recommendations-dpd-testing-prior-treatment-fluorouracil-capecitabine-tegafur-flucytosine

    EMA
    01 May 2020
    Share Share